Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Eton Pharmaceuticals (ETON) over the last 3 years, with Q3 2025 value amounting to 0.1%.

  • Eton Pharmaceuticals' Return on Invested Capital rose 1800.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.07% for FY2024, which is 200.0% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Return on Invested Capital of 0.1% as of Q3 2025, which was up 1800.0% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Return on Invested Capital ranged from a high of 0.02% in Q1 2024 and a low of 0.34% during Q2 2024
  • For the 3-year period, Eton Pharmaceuticals' Return on Invested Capital averaged around 0.12%, with its median value being 0.08% (2023).
  • Data for Eton Pharmaceuticals' Return on Invested Capital shows a peak YoY increase of 3200bps (in 2025) and a maximum YoY decrease of -700bps (in 2025) over the last 5 years.
  • Eton Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.09% in 2023, then grew by 21bps to 0.07% in 2024, then tumbled by -50bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.02% for Q2 2025, and 0.04% during Q1 2025.